CPC Subgroup
A61K 31/505 Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
Full Title
Medicinal preparations containing organic active ingredients > Heterocyclic compounds > having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins > having six-membered rings with two nitrogen atoms as the only ring heteroatoms, e.g. piperazine (A61K31/48 takes precedence ) > Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
6 direct subcodes
Child Classifications
Navigate with arrow keys, Enter to open
- A61K 31/506 not condensed and containing further heterocyclic rings
- A61K 31/513 having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
- A61K 31/517 ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
- A61K 31/519 ortho- or peri-condensed with heterocyclic rings
- A61K 31/527 spiro-condensed
- A61K 31/529 forming part of bridged ring systems
Top Applicants
Top 10 applicants by patent filingsfor class A61, 2013–2023, worldwide · Source: EPO PATSTAT
- PHILIPS ELECTRONICS NL 20,621
- NOVARTIS CH 15,792
- ROCHE CH 14,303
- COVIDIEN US 13,862
- HARVARD UNIVERSITY US 13,454
- UNIVERSITY OF CALIFORNIA US 12,798
- P&G (PROCTER & GAMBLE COMPANY) US 12,140
- L'OREAL FR 11,800
- OLYMPUS CORPORATION JP 9,894
- BOSTON SCIENTIFIC SCIMED US 9,513